FDA NDC Directory · JSON-LD · Markdown

OPDIVO QVANTIG

NDC 0003-6120 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namenivolumab and hyaluronidase-nvhy
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryBiologic License Application · App BLA761381
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (2000 U/mL)
NIVOLUMAB (120 mg/mL)
Marketing started20250102
Package count1

External sources

Source: openFDA. Public-domain (CC0).